Evidence map›Paper›PMID 16690620›Full record

ArticleThe Journal of biological chemistry2006

Beta8 integrin binds Rho GDP dissociation inhibitor-1 and activates Rac1 to inhibit mesangial cell myofibroblast differentiation.

Sujata Lakhe-Reddy, Shenaz Khan, Martha Konieczkowski, George Jarad, Karen L Wu, Louis F Reichardt, Yoshimi Takai, Leslie A Bruggeman, Bingcheng Wang, John R Sedor and 1 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.2field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Blocking immunosuppression by human Tregs in vivo with antibodies targeting integrin αVβ8.Proceedings of the National Academy of Sciences of the United States of America · 2017
    Article
  5. Article
  6. Article
  7. Article
  8. Mesangial cell αvβ8-integrin regulates glomerular capillary integrity and repair.American journal of physiology. Renal physiology · 2014
    Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Sujata Lakhe-ReddyDepartment of Medicine, Case Western Reserve University School of Medicine, Rammelkamp Center for Education and Research, MetroHealth Medical Center, Cleveland, Ohio 44109, USA.
Shenaz Khan
Martha Konieczkowski
George Jarad
Karen L Wu
Louis F Reichardt
Yoshimi Takai
Leslie A Bruggeman
Bingcheng Wang
John R Sedor
Jeffrey R Schelling
MetroHealth Medical Center · USCase Western Reserve University · USHoward Hughes Medical Institute · USOsaka University · JP

Funding

STUDIES ON A NEURTITE OUTGROWTH FACTORR01NS019090 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI REICHARDT, LOUIS FRENCH · 1985 to 2009
$3.4M
TARGETING RENAL OUTER MEDULLARY K+ CHANNEL ROMK FOR NEW CLASS OF DIURETICSP50DK054178 · NIDDK · CASE WESTERN RESERVE UNIVERSITY · PI CARLIN, CATHLEEN R · 1998 to 2002
$2.2M
Transcriptional regulation in chronic renal disease pathogenesisR01DK061395 · NIDDK · CASE WESTERN RESERVE UNIVERSITY · PI BRUGGEMAN, LESLIE A · 2001 to 2008
$1.6M
EphA2 Agonists as Novel Inhibitors of Tumor ProgressionR01CA092259 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI WANG, BINGCHENG · 2002 to 2007
$1.4M
Mechanisms of Glomerular ScarringR01DK064719 · NIDDK · CASE WESTERN RESERVE UNIVERSITY · PI SEDOR, JOHN R. · 2003 to 2006
$1.2M
Eph Kinase Signaling in Prostate CancerR01CA096533 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI WANG, BINGCHENG · 2001 to 2004
$954k
NCI NIH HHS R01 CA092259NCI NIH HHS R01 CA096533NIDDK NIH HHS P50 DK054178NIDDK NIH HHS R01 DK061395NIDDK NIH HHS R01 DK064719NINDS NIH HHS R01 NS019090
6 · The paper itself

Abstract

Alpha(v)beta8 integrin expression is restricted primarily to kidney, brain, and placenta. Targeted alpha(v) or beta8 deletion is embryonic lethal due to defective placenta and brain angiogenesis, precluding investigation of kidney alpha(v)beta8 function. We find that kidney beta8 is localized to glomerular mesangial cells, and expression is decreased in mouse models of glomerulosclerosis, suggesting that beta8 regulates normal mesangial cell differentiation. To interrogate beta8 signaling pathways, yeast two-hybrid and co-precipitation studies demonstrated beta8 interaction with Rho guanine nucleotide dissociation inhibitor-1 (GDI). Selective beta8 stimulation enhanced beta8-GDI interaction as well as Rac1 (but not RhoA) activation and lamellipodia formation. Mesangial cells from itgb8-/- mice backcrossed to a genetic background that permitted survival, or gdi-/- mice, which develop glomerulosclerosis, demonstrated RhoA (but not Rac1) activity and alpha-smooth muscle actin assembly, which characterizes mesangial cell myofibroblast transformation in renal disease. To determine whether Rac1 directly modulates RhoA-associated myofibroblast differentiation, mesangial cells were transduced with inhibitory Rac peptide fused to human immunodeficiency virus-Tat, resulting in enhanced alpha-smooth muscle actin organization. We conclude that the beta8 cytosolic tail in mesangial cells organizes a signaling complex that culminates in Rac1 activation to mediate wild-type differentiation, whereas decreased beta8 activation shifts mesangial cells toward a RhoA-dependent myofibroblast phenotype.

Indexed as

AnimalsCell DifferentiationFibroblastsGlomerulosclerosis, Focal SegmentalGuanine Nucleotide Dissociation InhibitorsIntegrin alphaVIntegrin beta ChainsKidneyMiceMice, TransgenicPhenotypeProtein Bindingrac1 GTP-Binding ProteinSignal TransductionGDP dissociation inhibitor 1Guanine Nucleotide Dissociation InhibitorsIntegrin alphaVintegrin beta8Integrin beta Chainsrac1 GTP-Binding Protein

Identifiers

PMID16690620
PMCPMC2711893
OpenAlexW2134153708

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.